CLINICAL-PHARMACOLOGY OF BRUCEANTIN BY RADIOIMMUNOASSAY

被引:4
作者
FONG, KLL
HO, DHW
BENJAMIN, RS
BROWN, NS
BEDIKIAN, A
YAP, BS
WISEMAN, CL
KRAMER, W
BODEY, GP
机构
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT DEV THERAPEUT,HOUSTON,TX 77030
[2] UNIV HOUSTON,COLL PHARM,DEPT PHARMACEUT,HOUSTON,TX 77030
关键词
D O I
10.1007/BF00257747
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:169 / 172
页数:4
相关论文
共 16 条
[1]  
BEDIKIAN AY, 1979, CANCER TREAT REP, V63, P1843
[2]  
CASTLES TR, 1976, PB257175, P348
[3]  
DOUROS J, 1978, CANCER CHEMOTH PHARM, V1, P91
[4]   RADIOIMMUNOASSAY FOR THE DETECTION AND QUANTITATION OF BRUCEANTIN [J].
FONG, KLL ;
HO, DHW ;
CARTER, CJK ;
BROWN, NS ;
BENJAMIN, RS ;
FREIREICH, EJ ;
BODEY, GP .
ANALYTICAL BIOCHEMISTRY, 1980, 105 (02) :281-286
[5]   BRUCEANTIN, A NOVEL INHIBITOR OF PEPTIDE-BOND FORMATION [J].
FRESNO, M ;
GONZALES, A ;
VAZQUEZ, D ;
JIMENEZ, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 518 (01) :104-112
[6]  
GARNICK MB, 1979, CANCER TREAT REP, V63, P1929
[7]  
HARTWELL JL, 1976, CANCER TREAT REP, V60, P1031
[8]   ISOLATION AND STRUCTURAL ELUCIDATION OF BRUCEANTIN AND BRUCEANTINOL, NEW POTENT ANTILEUKEMIC QUASSINOIDS FROM BRUCEA-ANTIDYSENTERICA [J].
KUPCHAN, SM ;
BRITTON, RW ;
LACADIE, JA ;
ZIEGLER, MF ;
SIGEL, CW .
JOURNAL OF ORGANIC CHEMISTRY, 1975, 40 (05) :648-654
[9]   TUMOR INHIBITORS .82. BRUCEANTIN, A NEW POTENT ANTILEUKEMIC SIMAROUBOLIDE FROM BRUCEA-ANTIDYSENTERICA [J].
KUPCHAN, SM ;
BRITTON, RW ;
ZIEGLER, MF ;
SIGEL, CW .
JOURNAL OF ORGANIC CHEMISTRY, 1973, 38 (01) :178-179
[10]  
LIAO LL, 1976, MOL PHARMACOL, V12, P167